본문 바로가기
KERD
논문KCI 등재

Diagnosis and treatment of cystic lung disease

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류내과학

초록

Cystic lung disease (CLD) is a group of lung disorders characterized by the presence of multiple cysts, defined as air-filled lucencies or low-attenuating areas, bordered by a thin wall (usually < 2 mm). The recognition of CLDs has increased with the widespread use of computed tomography. This article addresses the mechanisms of cyst formation and the diagnostic approaches to CLDs. A number of assessment methods that can be used to confirm CLDs are discussed, including high-resolution computed tomography, pathologic approaches, and genetic/ serologic markers, together with treatment modalities, including new therapeutic drugs currently being evaluated. The CLDs covered by this review are lymphangioleiomyomatosis, pulmonary Langerhans cell histiocytosis, Birt-Hogg-Dube syndrome, lymphocytic interstitial pneumonia/follicular bronchiolitis, and amyloidosis.

Abstract

Cystic lung disease (CLD) is a group of lung disorders characterized by the presence of multiple cysts, defined as air-filled lucencies or low-attenuating areas, bordered by a thin wall (usually < 2 mm). The recognition of CLDs has increased with the widespread use of computed tomography. This article addresses the mechanisms of cyst formation and the diagnostic approaches to CLDs. A number of assessment methods that can be used to confirm CLDs are discussed, including high-resolution computed tomography, pathologic approaches, and genetic/ serologic markers, together with treatment modalities, including new therapeutic drugs currently being evaluated. The CLDs covered by this review are lymphangioleiomyomatosis, pulmonary Langerhans cell histiocytosis, Birt-Hogg-Dube syndrome, lymphocytic interstitial pneumonia/follicular bronchiolitis, and amyloidosis.

참고문헌 (57)

  1. Hansell DM, "Fleischner Society: glossary of terms for thoracic imaging", Radiology, 246, pp.697~722 (2008)
  2. 박혜윤, "A Nationwide Survey of Lymphangioleiomyomatosis in Korea: Recent Increase in Newly Diagnosed Patients", Journal of Korean Medical Science, 25(8), pp.1182~1186 (2010), 대한의학회
  3. Copley SJ, "Lung morphology in the elderly: comparative CT study of subjects over 75 years old versus those under 55 years old", Radiology, 251, pp.566~573 (2009)
  4. Gupta N, "Diffuse cystic lung disease: part I", Am J Respir Crit Care Med, 191, pp.1354~1366 (2015)
  5. 권용수, "Mycobacterium avium lung disease combined with a bronchogenic cyst in an immunocompetent young adult", The Korean Journal of Internal Medicine, 28(1), pp.94~97 (2013), 대한내과학회[DOI]
  6. Dines DE., "Diagnostic significance of pneumatocele of the lung", AMA, 204, pp.1169~1172 (1968)
  7. Kikuchi E, "Epithelioid sarcoma presenting as pulmonary cysts with cancer antigen 125 expression", Respirology, 11, pp.826~829 (2006)
  8. Seaman DM, "Diffuse cystic lung disease at high-resolution CT", AJR Am J Roentgenol, 196, pp.1305~1311 (2011)
  9. Clarke BE., "Cystic lung disease", J Clin Pathol, 66, pp.904~908 (2013)
  10. So-Yeon Jeon, "Epithelioid sarcoma with spontaneous pneumothorax and massive pleural effusion", The Korean Journal of Internal Medicine, 31(1), pp.191~193 (2016), 대한내과학회[DOI]
  11. Lee KN, "Cystic lung disease: a comparison of cystic size, as seen on expiratory and inspiratory HRCT scans", Korean J Radiol, 1, pp.84~90 (2000)
  12. Ohdama S, "Primary diffuse alveolar septal amyloidosis with multiple cysts and calcification", Eur Respir J, 9, pp.1569~1571 (1996)
  13. Masuzawa M, "Association of D2-40 and MMP-1 expression with cyst formation in lung metastatic lesions of cutaneous angiosarcoma on the scalp: immunohistochemical analysis of 23 autopsy cases", Hum Pathol, 44, pp.2751~2759 (2013)
  14. Goncharova EA, "Prevention of alveolar destruction and airspace enlargement in a mouse model of pulmonary lymphangioleiomyomatosis (LAM)", Sci Transl Med, 4, pp.154ra134~ (2012)
  15. Kumasaka T, "Characterization of pulmonary cysts in Birt-Hogg-Dube syndrome: histopathological and morphometric analysis of 229 pulmonary cysts from 50 unrelated patients", Histopathology, 65, pp.100~110 (2014)
  16. Goncharova EA, "Folliculin controls lung alveolar enlargement and epithelial cell survival through E-cadherin, LKB1, and AMPK", Cell Rep, 7, pp.412~423 (2014)
  17. Trotman-Dickenson B., "Cystic lung disease: achieving a radiologic diagnosis", Eur J Radiol, 83, pp.39~46 (2014)
  18. Ferreira Francisco FA, "Multiple cystic lung disease", Eur Respir Rev, 24, pp.552~564 (2015)
  19. Gupta N, "Diffuse cystic lung disease: part II", Am J Respir Crit Care Med, 192, pp.17~29 (2015)
  20. Harari S, "The changing face of a rare disease: lymphangioleiomyomatosis", Eur Respir J, 46, pp.1471~1485 (2015)
  21. Badalian-Very G, "Recurrent BRAF mutations in Langerhans cell histiocytosis", Blood, 116, pp.1919~1923 (2010)
  22. Johnson SR, "European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis", Eur Respir J, 35, pp.14~26 (2010)
  23. Meraj R, "Lymphangioleiomyomatosis: new concepts in pathogenesis, diagnosis, and treatment", Semin Respir Crit Care Med, 33, pp.486~497 (2012)
  24. Samueli S, "Tuberous sclerosis complex: new criteria for diagnostic work-up and management", Wien Klin Wochenschr, 127, pp.619~630 (2015)
  25. Tobino K, "Computed tomographic features of lymphangioleiomyomatosis: evaluation in 138 patients", Eur J Radiol, 84, pp.534~541 (2015)
  26. Hayashi T, "Prevalence of uterine and adnexal involvement in pulmonary lymphangioleiomyomatosis:a clinicopathologic study of 10patients", Am J Surg Pathol, 35, pp.1776~1785 (2011)
  27. Glasgow CG, "Serum vascular endothelial growth factor-D levels in patients with lymphangioleiomyomatosis reflect lymphatic involvement", Chest, 135, pp.1293~1300 (2009)
  28. Young LR, "Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases", Chest, 138, pp.674~681 (2010)
  29. Davies DM, "Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: a phase 2 trial", Clin Cancer Res, 17, pp.4071~4081 (2011)
  30. McCormack FX, "Efficacy and safety of sirolimus in lymphangioleiomyomatosis", N Engl J Med, 364, pp.1595~1606 (2011)
  31. Taveira-DaSilva AM, "Changes in lung function and chylous effusions in patients with lymphangioleiomyomatosis treated with sirolimus", Ann Intern Med, 154, pp.797~805 (2011)
  32. Bissler JJ, "Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial", Lancet, 381, pp.817~824 (2013)
  33. Goldberg HJ, "Everolimus for the treatment of lymphangioleiomyomatosis: a phase II study", Eur Respir J, 46, pp.783~794 (2015)
  34. Hammes SR, "Targeted approaches toward understanding and treating pulmonary lymphangioleiomyomatosis (LAM)", Horm Cancer, 4, pp.70~77 (2013)
  35. Moir LM., "Lymphangioleiomyomatosis: current understanding and potential treatments", Pharmacol Ther, 158, pp.114~124 (2016)
  36. Jawad H, "Cystic interstitial lung diseases: recognizing the common and uncommon entities", Curr Probl Diagn Radiol, 43, pp.115~127 (2014)
  37. Bernstrand C, "Smoking preceded pulmonary involvement in adults with Langerhans cell histiocytosis diagnosed in childhood", Acta Paediatr, 89, pp.1389~1392 (2000)
  38. Casolaro MA, "Accumulation of Langerhans’ cells on the epithelial surface of the lower respiratory tract in normal subjects in association with cigarette smoking", Am Rev Respir Dis, 137, pp.406~411 (1988)
  39. Yousem SA, "Pulmonary Langerhans’ cell histiocytosis: molecular analysis of clonality", Am J Surg Pathol, 25, pp.630~636 (2001)
  40. Suri HS, "Pulmonary langerhans cell histiocytosis", Orphanet J Rare Dis, 7, pp.16~ (2012)
  41. Sahm F, "BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis", Blood, 120, pp.e28~e34 (2012)
  42. Tazi A, "Serial computed tomography and lung function testing in pulmonary Langerhans’cell histiocytosis", Eur Respir J, 40, pp.905~912 (2012)
  43. Brauner MW, "Pulmonary histiocytosis X: evaluation with high-resolution CT", Radiology, 172, pp.255~258 (1989)
  44. Lorillon G, "Cladribine is effective against cystic pulmonary Langerhans cell histiocytosis", Am J Respir Crit Care Med, 186, pp.930~932 (2012)
  45. Hyman DM, "Vemurafenib in multiple nonmelanoma cancers with BRAF V600 mutations", N Engl J Med, 373, pp.726~736 (2015)
  46. Le Pavec J, "Pulmonary Langerhans cell histiocytosis-associated pulmonary hypertension:clinical characteristics and impact of pulmonary arterial hypertension therapies", Chest, 142, pp.1150~1157 (2012)
  47. Gupta N, "Pulmonary manifestations of Birt-Hogg-Dube syndrome", Fam Cancer, 12, pp.387~396 (2013)
  48. Agarwal PP, "Thoracic CT findings in Birt-Hogg-Dube syndrome", AJR Am J Roentgenol, 196, pp.349~352 (2011)
  49. 서명숙, "낭종성 폐병변으로 내원하여 진단된 Birt-Hogg-Dubé 증후군 2예", 대한내과학회지, 87(4), pp.477~483 (2014), 대한내과학회[DOI]
  50. Dal Sasso AA, "Birt-Hogg-Dube syndrome: state-of-the-art review with emphasis on pulmonary involvement", Respir Med, 109, pp.289~296 (2015)
  51. Stamatakis L, "Diagnosis and management of BHD-associated kidney cancer", Fam Cancer, 12, pp.397~402 (2013)
  52. Tian X, "Lymphocytic interstitial pneumonia and other benign lymphoid disorders", Semin Respir Crit Care Med, 33, pp.450~461 (2012)
  53. Carrillo J, "Lymphoproliferative lung disorders: a radiologic-pathologic overview. Part I:reactive disorders", Semin Ultrasound CT MR, 34, pp.525~534 (2013)
  54. Richards JC, "Cystic and nodular lung disease", Clin Chest Med, 36, pp.299~312 (2015)
  55. Cordier JF., "Pulmonary amyloidosis in hematological disorders", Semin Respir Crit Care Med, 26, pp.502~513 (2005)
  56. Rajagopala S, "Pulmonary amyloidosis in Sjogren’s syndrome: a case report and systematic review of the literature", Respirology, 15, pp.860~866 (2010)
  57. Zamora AC, "Amyloid-associated cystic lung disease", Chest, 149, pp.1223~1233 (2016)

관련 논문AI추천

이 간행물의 다른 논문 (23건)